Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Convergent Dental Announces New Clinical Advisory Board to Help Shape the Future of Laser Dentistry and Patient Care


“Solea is a multiplier at the center of the practice. It enables dentists to streamline current procedures and expand to new procedures while complementing adjacent technologies,” said Robert L. Gershon, CEO of Convergent Dental. “Our new clinical advisors have years of experience with Solea and understand firsthand the multitude of ways this laser can benefit patients and practices. We look forward to the insights they will bring to our growth strategy as we continue to drive the broad-based adoption of Solea.”

The new Convergent Clinical Advisory Board features the following Solea dentists. Dr. Tim Anderson founded Missouri River Dental as a startup private practice in Bismarck, ND. After receiving his Doctor of Dental Surgery from the University of Minnesota School of Dentistry, he completed his general practice residency at Hennepin County Medical Center (Level 1 Trauma Center).

His practice and philosophy are grounded in the belief that technology helps dentists to work smarter, have more fun, and ignite their passion for their business, all while improving the patient experience and achieving better clinical outcomes. He leverages CAD/CAM, CBCT, 3D printing, and CO2 laser technology to deliver comprehensive, quality oral health care that is patient-centered.

In addition to clinical dentistry, Dr. Anderson maintains a leadership role within the dental profession and lectures on various dental technology topics around the country. He is a Key Opinion Leader (KOL) in the areas of dental lasers and 3D Printing. He invests his time and knowledge as a faculty member at 3D Dentists to help other dental professionals nationally discover what digital technology can do for their practices.

Dr. Jeff Rohde currently maintains an innovative restorative and surgical practice in Santa Barbara, CA. He graduated from UCLA with a bachelor’s degree in microbiology and molecular genetics and a master’s degree in biochemistry. He continued his studies at UCLA in the School of Dentistry, graduating with numerous awards. In 2006, Dr. Rohde became one of the founders of Dentalcompare, an online resource that specializes in helping doctors learn about new products and techniques. His practice integrates multiple technologies including the Solea All-Tissue laser, Cone Beam, CAD/CAM, and 3D printing. Dr. Rohde has authored dozens of articles and is an international speaker, covering topics such as digital dentistry, laser dentistry, advanced surgical techniques, and clear aligner therapy.

Dr. Christopher Blair graduated with a B.Sc. in chemistry from York University before completing his Doctor of Dental Surgery Degree at the University of Toronto where he was the recipient of the Dean’s Gold Medal. After graduation, he completed a general practice residency at The Toronto General Hospital. Dr. Blair now maintains a general practice in Oakville, Ontario. He is an avid cyclist and has often combined his passion for cycling with charitable endeavors. Most notably, Dr. Blair is passionate about his efforts to raise funds to support kids living with cancer and who are cancer survivors and to support cancer research. Through his participation in Tour for Kids and The Ride to Conquer Cancer, Dr. Blair has raised thousands of dollars to support Camp Trillium, Camp Quality, and Camp Oochegeas, as well as The Princess Margaret Cancer Centre.

Dr. Jenny Jackson graduated as valedictorian with a degree in microbiology from North Carolina State before attending the Harvard School of Dental Medicine where she was given the Dean’s Community Service Award and was chosen to be a part of the HSDM/Forsyth Institute Research Academy. With a passion for helping children, Dr. Jackson opened her own practice in Asheville, NC in 2007. She currently serves as immediate past president of the North Carolina Academy of Pediatric Dentistry, is an adjunct assistant professor at University of North Carolina Chapel Hill Dental School, and is recognized as a Fellow of the American Academy of Pediatric Dentistry for leadership and service in the field of Pediatric Dentistry.

Dr. Jared Poplin graduated from the University of Kansas with a B.A. in biology. He earned his Doctorate in Dental Medicine from Temple University School of Dentistry and achieved an additional two-year pediatric residency at St. Christopher’s Hospital for Children in Philadelphia while working in a private pediatric dental office. Dr. Poplin has extensive training and experience in nitrous oxide, general anesthesia, and dental trauma. He is also a Diplomate of the American Board of Pediatric Dentistry. Dr. Poplin has volunteered with the Haitian Health Foundation to provide dental care in the rural villages of Haiti. He excels at working with children who are extremely fearful as well as children with special needs.

To learn more about the Solea® All-Tissue Dental Laser, visit www.ConvergentDental.com.

About Convergent Dental

Convergent Dental, Inc. is a privately owned dental equipment and technology company. The Company’s flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers virtually anesthesia-free, blood-free, pain-free experiences that dentists can rely on. Solea is a true breakthrough in dental laser technology that offers a completely different experience for both dentists and patients when compared to traditional instruments or any earlier laser treatment. Solea® enables increased new patient flow, better clinical outcomes, significant efficiency gains, and the addition of new procedures. Follow the company on Instagram, Facebook, and LinkedIn.

Media Contact

Caitlin D’Entremont, Convergent Dental, 1 508-500-5656, [email protected], https://www.convergentdental.com/ 

Barbara Tabor, Tabor PR, 1 651-230-9192, [email protected]

Twitter, LinkedIn

SOURCE Convergent Dental



Cleo Unveils Global Launch of Evidence-based Support Plans, Real-time Family Health Reports and Personalized Self-Care to Revolutionize Caregiving Experience


Additionally, Cleo members now have the ability to add themselves as a caregiving recipient, in order to ensure that they’re taking care of themselves while caring for others as well as plan for their own current and future care needs.

+ Support Plans: Foundational and Targeted Care for Specific Needs

Cleo’s new Support Plans provide a seamless and structured approach to caregiving by offering tailored tasks and interventions to address a wide range of parenting and caregiving concerns.

Every Cleo member receives a Support Plan for each individual they are caring for, as well as one for themselves, which each consist of tasks based on family details they’ve shared with Cleo. This foundational level of support ensures that caregivers have a structured plan to follow right from the start. Support Plans can help a member with some of the more challenging milestones along a typical journey, such as parenting a toddler or raising a teenager, or also provide in-depth support tailored to specific caregiving conditions, such as high-risk pregnancy, ADHD, learning disabilities, Alzheimer’s/Dementia, falls in the elderly, and others.

Each Support Plan is composed of evidence-based actions that align with the recipient’s support requirements, designed to achieve targeted successful outcomes for the entire family unit.

+ Real-time Member Reports for Family Health IndexTM

Cleo builds upon its successful, measureable framework of the Family Health IndexTM by launching real-time member reports, allowing Cleo members to identify and engage with potential issues before they cause burnout, absenteeism, or mental health issues.

The Family Health IndexTM measures seven dimensions of family health: confidence, caregiver burden, self-care, general health, emotional wellness, connectedness, and family support. Now, members can take the Family Health IndexTM assessment and immediately see their score, receive targeted interventions for the dimensions they can improve on, and track progress over time.

+ Self-Care for Cleo Members

About 27% of white-collar workers say they would quit and look for new jobs if their employer didn’t do a better job of addressing their mental health needs (Fortune). Additionally, the cost of burnout, absenteeism, and mental health care costs are a significant burden on employers, and caregivers experience some of the worst mental health among employees.

Cleo members have always been supported with emotional wellness, balancing career and family, returning to work after leave, and more. Now, that support is provided programmatically through Cleo’s Self-Care offering, which features expanded topics, education, and expert sessions including taking care of myself, managing menopause, planning for future care, navigating family support, and more. Self-Care is included for Cleo members and employers, helping individuals stay engaged as a caregiver and employee alike during some of life’s most challenging moments.

+ Measuring Success, Impacting Lives

Cleo’s Support Plans, Family Health IndexTM, and Self-Care features are built on a foundation of evidence-based, best-practice resources and interventions known as High-Value Interventions. These interventions are meticulously crafted to drive behavior changes that directly impact Cleo’s outcomes across different stages of life, fostering measurable improvement in the lives of caregivers and care recipients—and delivering results to employers. This includes reducing hospitalization rates in newborns, higher return-to-work rates, decreasing burnout, increased productivity, decreased attrition, and many more.

“With our outcomes-focused framework, we’re not only providing the tools for better caregiving but also tracking and measuring our impact on key outcome areas,” said Madhavi Vemireddy, physician and CEO at Cleo. “This launch marks a significant step forward in Cleo’s mission to enhance the quality of life for caregivers and their care recipients alike.”

+ About Cleo

Cleo, founded in 2016 by a clinician, has evolved to become the most comprehensive global support network for parents and caregivers, providing end-to-end trustworthy, inclusive support through all stages and phases of life. Cleo is now the leading global family support benefit trusted by 180+ forward-thinking employers to support families, improve health outcomes, control costs and attrition, and build inclusive cultures of care.

Cleo families are happier, healthier, and more productive and engaged as they balance their roles at home and at work. Cleo customers experience less attrition rates – Cleo members are 30% less likely to be planning to leave their job than non-Cleo working parents. Cleo is creating a more equitable work world where everyone wins: employees are more supported and therefore more successful at work and home, and employers see their bottom line improved through higher retention, improved health outcomes, decreased absenteeism, and a culture of inclusivity that stands the test of time.

Cleo believes in challenging the care status quo, and in doing so envisions a world where caregiver support is more democratized, and all caregivers feel as nurtured and supported as they deserve to be.

For media inquiries, please contact [email protected].

For more information about Cleo Support Plans, the Family Health IndexTM, and Self-Care, please visit hicleo.com.

Media Contact
Cleo Public Relations, Cleo, 1 646-413-0806, [email protected], hicleo.com

SOURCE Cleo

LPG® America Celebrates Grand Opening as the Newest Subsidiary of the LPG® Group


Inspired by manual massage, endermologie® is the exclusive principle of action of LPG® patented technologies. It mechanically stimulates the skin’s surface to reactivate dormant cellular activity. It is a 100% natural, non-invasive and non-aggressive technique with scientifically-proven results (165+ scientific studies, out of which 90 published on Medline).

Their flagship products, including the CELLU M6 Alliance®, have revolutionized the industry by reactivating cells through mechanical massage, benefiting countless individuals worldwide.

The Grand Opening will be a blend of elegance and innovation. The LPG® Group’s CEO, Thierry Gee, joining from France, will be a distinguished guest for the evening. One of the evening’s highlights will be the inauguration of LPG® America’s brand-new office space, reflecting the brand’s commitment to growth, excellence in the US market and future-forward vision.

“This Grand Opening is not just a celebration of a new office space; it’s a testament to our dedication to bringing non-aggressive and non-invasive treatment solutions to the American market,” said Thierry Gee CEO of LPG® Group.

As a token of appreciation, guests will receive exclusive branded gift bags, embodying the brand’s essence. Since the acquisition of the US distributor in December 2021, LPG® America has been on a mission to expand and solidify the brand’s presence, with a focus on customer support as the foundation of its success.

LPG® America’s mission remains clear: to provide unparalleled customer support and foster lasting relationships. With this Grand Opening, the brand takes a significant step towards realizing its vision of becoming a household name in the USA.

About LPG® America:
LPG® America, as part of the LPG® Group, continues the legacy of providing non-aggressive and non-invasive treatment solutions. With 28,000 professionals equipped worldwide and 84,000 individuals receiving endermologie® treatments daily, the brand stands as a testament to quality and innovation in the healthcare and beauty sectors.

Location: 2966 Northwest 60 Street Fort Lauderdale, FL 33309
Toll-Free Number: 866-374-9401

Connect with us on Social Media:
LinkedIn →Instagram →

Media Contact

Tyler Gurczeski, Exults Digital Marketing, 866-374-9401, [email protected], https://www.endosystems.us/

SOURCE LPG® America



Innovation Takes Center Stage at the 2023 PDA Pharmaceutical Microbiology Conference


“Microbiologists and regulators are tasked with answering big and difficult questions, and this can only be achieved by continuing to build our competence, sharing experiences and challenges, and keeping the discipline of pharmaceutical microbiology strong and vibrant,” said conference co-chair Kurt Jaecques, GSK.

“For this year’s conference, PDA and the Program Planning Committee are proud to present a robust program that tackles both current and future issues that will impact pharmaceutical microbiology,” said conference co-chair Vineeta Pradhan, U.S. FDA.

Day one will open with a plenary presentation by three-time cancer survivor Rob Weker, whose story will remind attendees of the enormous purpose of their work in pharmaceutical microbiology. The remainder of the day is packed with concurrent sessions covering multiple, forward-looking topics. Day one concludes with a presentation on pathogen spillover into humans by Assistant Professor of Biology David Kennedy, MD, Pennsylvania State University, who will share insights on a model that will be able to predict the likelihood of microbial transmission. Dr. Kennedy will discuss his research model of using nematodes as a unique host organism and how this model promises to predict future crossovers before they develop into global pandemics.

Day two features more expert discussions of all-important topics like environmental monitoring, risk management and data governance, contamination control strategies, and case studies on the implementation of the new European Union Annex 1: Manufacture of Sterile Medicinal Products.

Day three’s headliner is an eye-opening plenary session featuring Elisabeth Bik, PhD, a scientific integrity consultant and founder of the Science Integrity Digest blog. Dr. Bik will share insights on image duplication, manipulation and other problems in biomedical research. She is known for her work on detecting photomanipulations in scientific publications.

The 18th PDA Pharmaceutical Microbiology Conference concludes with the ever popular “Ask the Regulators” session, where U.S. FDA representatives will field questions posed by the audience.

Click here for more information on the 2023 PDA Pharmaceutical Microbiology Conference.

To request a press pass, click here.

Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation, so members can better serve patients. Go to http://www.pda.org/footer/about-pda to learn more.

Media Contact

Walter Morris, www.pda.org, 1 3016565900, [email protected], www.pda.org

SOURCE www.pda.org

The opportunity within the Fill Finish Manufacturing of Biologics Market to grow at ~10% CAGR till 2035, according to a market research report by Roots Analysis



The requirement for extensive capital investment and complex infrastructure for in-house filling of biologics has prompted biopharmaceutical companies to leverage the expertise of service providers for fill / finish of biologics LONDON, Sept. 12, 2023 /PRNewswire/ — Roots Analysis has…

Physician identifies types of fainting and when to seek medical attention


In anticipation of October’s Sudden Cardiac Arrest (SCA) Awareness Month, Contactor describes types of fainting, what fainting may signal about your heart health, and why you should seek medical attention directly after experiencing an episode to find out.

The most common type of syncope is vasovagal: fainting from a sudden drop in heart rate and blood pressure. Contractor describes a typical scenario: It is a hot day, you are dehydrated, and you’ve been standing for a long time. Suddenly, you feel nauseous, break out in a sweat, your face pales, a feeling of warmth envelops your body, and you gradually black out. In a few seconds, blood flow returns to your brain after being in a horizontal position, and you recover or wake up. After waking, you may feel exhausted.

When the brain senses that the heart is beating hard and blood pressure is high, Contractor says it sends an impulse throughout the body to relax. Blood stops reaching the brain during this maladaptive nervous system response, eventually making you faint.

Contractor warns to seek medical attention after any fainting episode, even if you suspect the cause was fatigue, heat, dehydration, or an emotional response.

“Sometimes a faint might seem vasovagal, but once you dive deeper, testing could reveal an underlying health concern,” Contractor says. “You want an expert to make this diagnosis and figure it out.”

If you experience this type of fainting frequently, Contractor says you will likely work with your care provider on lifestyle changes such as staying hydrated and wearing compression stockings. In some cases, he says you may wear a heart rhythm monitor to track your heart rate; based on the results, you and your physician will decide on the best treatment plan moving forward. For example, medications to raise blood pressure could help reduce fainting spells, Contractor says. In addition, a subset of patients could benefit from the implantation of a pacemaker, a small device placed in the chest to help control the heartbeat.

Other syncope scenarios that Contractor describes as “highly concerning” involve fainting out of the blue, without any symptoms (prodrome) during a period of inactivity — like sitting on the couch watching television — or in the midst of physical activity — like running across a basketball court and suddenly passing out.

These bouts of fainting may indicate the presence of cardiac arrhythmia, Contractor says. Arrhythmias occur when electrical impulses in the heart don’t work properly, causing an improper beating of the heart, whether irregular, too fast, or too slow. Arrhythmias are the most common cause of sudden cardiac arrest — the unexpected loss of heart function, breathing, and consciousness — according to the American Heart Association.

In these cases, Contractor says visiting the emergency department is the quickest way to obtain medical care. “You could faint again in a matter of minutes or hours,” he says. “You should be evaluated as soon as possible after the first episode, not five days later.”

The evaluation consists of testing via an electrocardiogram, an ultrasound of the heart, and possibly a heart rhythm monitor or coronary angiogram. Contractor says results from imaging will determine whether you need to undergo a cardiac MRI, receive an implantable cardioverter-defibrillator (ICD) to detect and stop irregular heartbeats, or obtain a pacemaker.

Someone who experiences this type of fainting may possess a slow heart rhythm that is malignant and requires a pacemaker, or they may be at risk for ventricular fibrillation — a life-threatening, fast heart rhythm from the heart’s bottom chamber. With ventricular fibrillation, the heart beats so fast that it doesn’t produce adequate blood flow to the brain. This type of arrhythmia is the most common one to cause cardiac arrest, Contractor says, and can cause irreversible brain damage and death.

“The bottom line is, don’t blow off a faint,” he says. “Seeing a doctor will help you understand the cause. You might rule out any heart problems, but even if a heart condition is found, you can take the right steps to ensure you’re safe from complications in the future.”

At Loma Linda University International Heart Institute, physicians are committed to providing patients with compassionate, comprehensive, and personalized cardiovascular care. To learn more, please visit lluh.org/heart-vascular. To schedule an interview with subject matter experts on this topic, please contact Lisa Aubry at [email protected].

Media Contact

Lisa Aubry, Loma Linda University Health, 9096515823, [email protected], news.llu.edu

SOURCE Loma Linda University Health

Long-term Outcomes of Radiation Techniques for Locally Advanced Non-Small Cell Lung Cancer Presented at IASLC 2023 Conference in Singapore


Concurrent photon-based chemoradiation is an established standard of care for unresectable locally advanced non-small cell lung cancer (NSCLC), However, the choice between IMRT and 3D-CRT has remained contentious due to limited prospective data. As IMRT is more labor-intensive and costlier than 3D-CRT, it is important to justify IMRT utilization based on long-term prospective outcomes.

The secondary analysis of NRG Oncology-RTOG 0617, spanning a median follow-up of 5.2 years, involved 482 patients with locally advanced NSCLC. Among them, 47% received IMRT and 53% received 3D-CRT. The study examined a range of parameters including 5-year overall survival (OS), progression-free survival (PFS), time to local failure (LF), distant metastasis-free survival (DMFS), adverse events, and the development of second malignancies.

Dr. Chun’s findings revealed that both IMRT and 3D-CRT groups exhibited similar OS, PFS, time to LF, and DMFS rates at the 5-year mark. Notably, IMRT was associated with a more than two-fold reduction in severe pneumonitis (3.5% vs. 8.2%) compared to 3D-CRT, demonstrating a clear advantage in reducing pulmonary toxicity.

Further analysis indicated a continuous association between heart V20-60Gy and survival, with heart V40Gy less than 20% linked to significantly improved survival rates. Multivariable analysis underscored the significance of heart V40Gy greater to or equal to 20% in predicting worse survival. In contrast, lung V5Gy did not significantly impact survival. Rates of second malignancy development were similar between IMRT and 3D-CRT groups.

Dr. Chun concluded that IMRT should be the preferred choice for locally advanced NSCLC to mitigate severe pulmonary toxicity and minimize radiation exposure to the heart. The study emphasized the importance of optimizing radiation planning, with special attention to reducing lung V20Gy and heart V20-60Gy, aiming for a heart V40Gy less than 20%. Encouragingly, the study did not find evidence that the low-dose bath (lung V5Gy) had a substantial impact on long-term survival or late severe toxicity.

These findings provide a crucial contribution to the ongoing discourse on radiation techniques for NSCLC treatment, paving the way for more informed clinical decisions and improved patient outcomes, according to Dr. Chun.

The study was supported by Eli Lily and Company and grants from the National Cancer Institute R50CA275822, U10CA180868, and U10CA180822.

About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association’s membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit http://www.iaslc.org for more information.

About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 countries. The goal is to increase awareness, collaboration, and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2023.iaslc.org. 

Media Contact

Chris Martin, IASLC, 6306702745, [email protected], https://wclc2023.iaslc.org.

SOURCE IASLC

From Beyond Time and Space Albert Einstein Will Provide CME Conference Physicians, PAs and NPs a Scientific Explanation of How to Reduce Their Burnout and Stress


According to Board Certified pulmonologist, critical care physician, and co-chair of AMI’s Department of Medical Education, Anthony Santilli MD, “My personal experience is that physicians today are subjected to an unprecedented number of significant stressors, including overwork, cumbersome regulation, electronic medical records and coding requirements, medical liability, on-call issues, lack of sleep, politics, and frustrations with the reimbursement structure. By attending this conference and learning to practice Yoga Science as Mind/Body Medicine, healthcare professionals can definitely improve their job satisfaction and work/life balance, while reducing and preventing burnout symptoms of anger, depression, anxiety and exhaustion.”

The entire “Heart and Science of Yoga” CME curriculum is a transformative learning experience. It is dedicated to providing quality, comprehensive and evidence-based education. Other topics this year will include an encyclopedic overview and instruction on AMI Meditation, Epigenetics, diaphragmatic breathing, mantra science, yoga psychology, mind function optimization, Food as Medicine, Ayurveda, easy-gentle yoga, lymph system detoxification and detailed instruction on how to employ knowledge of the Chakra System as a practical and reliable diagnostic tool.

The dedication, enthusiasm, and teaching methodology of the entire AMI faculty create a dynamic and interactive course for their students. Each faculty member is committed to the advancement and training of Yoga Science as Holistic Mind/Body Medicine. In addition to faculty director Leonard Perlmutter other presenters include: Mark Pettus MD, board certified internist and nephrologist and Director of Medical Education and Population Health of Berkshire Health Systems; Kristin Kaelber MD, PhD, board certified in Internal Medicine and Pediatrics; Renee Rodriguez-Goodemote, MD, Medical Director of the Saratoga Hospital Community Health Center; Anthony Santilli MD, board certified in Pulmonary and Critical Care Medicine; Jesse Ritvo MD, Assistant Medical Director, Inpatient Psychiatry, University of Vermont Health Center; Joshua Zamer, MD, Medical Director for Addiction Medicine at Saratoga Hospital Community Health Center and Chairman of the Department of Family Practice; Gustavo Grodnitzky PhD, Chair of the AMI Psychological Education Committee; Jenness Cortez Perlmutter, co-founder and faculty member of The American Meditation Institute; Anita Burock-Stotts, MD, board certified in Internal Medicine; and Janine Pardo MD, board certified in Internal Medicine.

About the American Meditation Institute

The American Meditation Institute is a 501(c)3 non-profit educational organization devoted to the teaching and practice of Yoga Science, AMI Meditation® and its allied disciplines as Mind/Body Medicine. In its holistic approach to wellness, AMI combines the healing arts, philosophy and spirituality of the East with the practicality of modern Western medical science. The American Meditation Institute offers a wide variety of courses, conferences and webinars. AMI also publishes “[Transformation” a bi-monthly journal of Yoga Science as Holistic Mind/Body Medicine.

Call 518.674.8714 for interviews with AMI Founder Leonard Perlmutter or an email subscription to “Transformation.”

Media Contact:
Robert Washington
PO Box 430
Averill Park, NY 12018
Tel: 518-674-8714
Fax: 518-674-8714

Media Contact
Robert Washington, American Meditation Institute, 5186748714, [email protected], AmericanMeditation.org

Twitter Facebook

SOURCE American Meditation Institute